Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

0.9821 +0.0123 (+1.27%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen Inc

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
33 34 Next >
OCGN Stock Alert: This Covaxin Update Is Sending Ocugen Rallying
Australia just gave a vote of confidence to Covaxin, sending OCGN stock climbing. However, the real catalyst rests in the hands of the WHO. 
Via InvestorPlace
Exposures COVID-19
2 Best Biotech Stocks to Buy in November
Bionano Genomics and Ocugen could both be gearing up for a healthy rally this month. 
Via The Motley Fool
28 Stocks Moving in Monday's Pre-Market Session
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 333.9% to $11.02 in pre-market trading. ABVC Biopharma’s S-3 showed registration for $50 million mixed securities shelf... 
Via Benzinga
4 Reasons Why Ocugen Will Make Very Little or No Money From Covaxin
Ocuigen is unlikely to be able to get Covaxin widely distributed in the U.S. until Spring 2023. By that time, it won't help OCGN stock much. 
Via InvestorPlace
Exposures COVID-19 Product Safety
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7... 
Via Benzinga
Tesla Remains Top WallStreetBets Interest; AMD, Ocugen, Facebook And These Are Other Top Trends Today
Tesla Inc. (NASDAQ:TSLA) continued to be the most-discusse... 
Via Benzinga
Ocugen Reverses Course From Monday's Massive Surge As COVID-19 Vaccine Partner Faces WHO Setback
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) fell 2% in Tuesday’s regular trading session after seeing strong gains on Monday. What Happened: Ocugen’... 
Via Benzinga
Exposures COVID-19
Tuesday Market Coverage
Thermo Electron fell on the publication of its social responsibility report today. 
Via Talk Markets
OCGN Stock Plunges After WHO Delays Decision on COVAXIN Vaccine
OCGN stock is capping off a day full of gains with a finish in the red. Late afternoon misfortune caused the stock to tank in value. 
Via InvestorPlace
Exposures COVID-19 Product Safety
Most Active Equity Options For Midday - Tuesday, Oct. 25
Top Tickers: TSLA, F, NVDA, FB, AAPL, AMD, PLTR, SNAP, NIO, LCID, INTC, DKNG, BAC, OCGN, MSFT, BABA, CLF, AMC, BKKT, PROG. 
Via Talk Markets
Ocugen Rallies Ahead Of WHO Meeting: What's Next?
Ocugen Inc. (NASDAQ: OCGN) shares are trading higher Tuesday ahead of a key World Health Organization meeting. The WHO meeting will decide whether or not to grant... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million,... 
Via Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Wallbox N.V. (NYSE: WBX) shares climbed 54.5% to $17.16. Uber and Wallbox N.V. disclosed a strategic partnership to simplify the transition to EVs for Bay Area ride... 
Via Benzinga
Why Ocugen Stock Is Skyrocketing Today
Investors are excited about a World Health Organization committee meeting on Tuesday. 
Via The Motley Fool
Exposures COVID-19
OCGN Stock Soars 30% as WHO Kicks Off COVAXIN Review
OCGN stock is racing higher as the WHO kicks off its review of partner Bharat Biotech's COVAXIN vaccine. Here's what to know. 
Via InvestorPlace
Exposures COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion.... 
Via Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 95.1% to $23.22 in pre-market trading after jumping around 24% on Monday. Diginex Limited (NASDAQ: EQOS) rose 74.5% to $7.... 
Via Benzinga
Ocugen Stock Strikes Massive Gains Day Ahead Of Key Date: What You Should Know
Shares of Ocugen Inc. (NASDAQ: OCGN) surged almost 12.3% in Monday’s regular trading session and another 38.5% in the after-hours session in anticipation of a key event... 
Via Benzinga
OCGN Stock Alert: What Is Going on With Red-Hot Ocugen Today?
Investors are in a speculative frenzy around COVAXIN ahead of a WHO meeting tomorrow. OCGN stock is rallying as a result. 
Via InvestorPlace
7 Reasons Why Novavax Is a No-Brainer Pick Over Ocugen
The advantages that Novavax offers are obvious. 
Via The Motley Fool
48 Biggest Movers From Yesterday
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO... 
Via Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to discuss the Chemistry, Manufacturing, and Controls (... 
Via Benzinga
Exposures Product Safety
3 Under-the-Radar COVID Stocks
Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too. 
Via The Motley Fool
Exposures COVID-19
16 Stocks Moving in Wednesday's Pre-Market Session
Gainers Troika Media Group, Inc. (NASDAQ: TRKA) rose 27.3% to $2.05 in pre-market trading after surging around 9% on Tuesday. The company, last month, said it swung to a loss in... 
Via Benzinga
3 Biotech Stocks That Are Ridiculously Overpriced
They've risen too far, too quickly. 
Via The Motley Fool
Ocugen Surged on Its Covid Vaccine Emergency Approval in India
OCGN stock has suffered as a Covid-19 vaccine latecomer, but news that Covaxin won emergency approval in India sent shares soaring. 
Via InvestorPlace
Exposures COVID-19
Is Now a Good Time to Buy Ocugen?
There is a lot of uncertainty surrounding this biotech's prospects. 
Via The Motley Fool
Exposures COVID-19
This Ocugen Stock Rally Makes Little Sense, But Watch Out Going Short
Despite the fact WHO approval for Covaxin means little for OCGN stock, shares could hold onto (o add to) their recent gains. 
Via InvestorPlace
Exposures COVID-19
Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001. 
Via The Motley Fool
Exposures COVID-19
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.